Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 22, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,665,772

« Back to Dashboard

Which drugs does patent 5,665,772 protect, and when does it expire?

Patent 5,665,772 protects AFINITOR, ZORTRESS, and AFINITOR DISPERZ, and is included in three NDAs. There have been zero Paragraph IV challenges on Afinitor Disperz, Afinitor, and Zortress.

Protection for AFINITOR has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

Summary for Patent: 5,665,772

Title: O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants
Abstract:Novel derivatives of rapamycin, particularly 9-deoxorapamycins, 26-dihydro-rapamycins, and 40-0-substituted and 28,40-0,0-di-substituted rapamycins, are found to have pharmaceutical utility, particularly as an immunosuppressants.
Inventor(s): Cottens; Sylvain (Witterswil, CH), Sedrani; Richard (Basel, CH)
Assignee: Sandoz Ltd. (Basel, CH)
Application Number:08/416,673
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
TABLET;ORAL022334-003Jul 9, 2010RXYesNo5,665,772*PED► SubscribeY
TABLET;ORAL022334-001Mar 30, 2009RXYesNo5,665,772*PED► SubscribeY
TABLET;ORAL022334-004Mar 30, 2012RXYesNo5,665,772*PED► SubscribeY
TABLET;ORAL022334-002Mar 30, 2009RXYesYes5,665,772*PED► SubscribeY
TABLET;ORAL021560-001Apr 20, 2010RXYesNo5,665,772*PED► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Foreign Priority and PCT Information for Patent: 5,665,772

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9221220Oct 09, 1992
PCT Information
PCT FiledSeptember 24, 1993PCT Application Number:PCT/EP93/02604
PCT Publication Date:April 28, 1994PCT Publication Number: WO94/09010

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus